Get access

Statins for influenza and pneumonia

  • Protocol
  • Intervention

Authors

  • Gulam Khandaker,

    Corresponding author
    1. The Children's Hospital at Westmead, National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia
    • Gulam Khandaker, National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, New South Wales, 2145, Australia. gulamk@chw.edu.au. tuhinmmc@yahoo.com.

    Search for more papers by this author
  • Harunor Rashid,

    1. Barts and the London School of Medicine and Dentistry, Centre for Paediatrics, London, UK
    Search for more papers by this author
  • Maria YK Chow,

    1. The Children's Hospital at Westmead, National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia
    Search for more papers by this author
  • Robert Booy

    1. The Children's Hospital at Westmead, National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to assess the efficacy and safety of statins in people with influenza and pneumonia. Comparisons will be made between people who have received statin therapy with those who have not received any statin therapy. This review will explore the following questions.

  1. Do statins reduce mortality from influenza and pneumonia?

  2. Do statins reduce morbidity and severity of influenza and pneumonia?

  3. How safe is it to administer statins to people with influenza and pneumonia?

Ancillary